vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and NewtekOne, Inc. (NEWT). Click either name above to swap in a different company.

NewtekOne, Inc. is the larger business by last-quarter revenue ($73.3M vs $73.1M, roughly 1.0× Evolus, Inc.). NewtekOne, Inc. runs the higher net margin — 111.8% vs -14.6%, a 126.4% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (6.7% vs -2.7%). Over the past eight quarters, NewtekOne, Inc.'s revenue compounded faster (12.2% CAGR vs 4.6%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

NewTek, Inc., is a hardware and software company, based in San Antonio, Texas, that produced live and post-production video tools and visual imaging software for personal computers. The company was founded in 1985 in Topeka, Kansas, United States, by Tim Jenison and Paul Montgomery. On April 1, 2019, it was announced that NewTek would be acquired by Vizrt.

EOLS vs NEWT — Head-to-Head

Bigger by revenue
NEWT
NEWT
1.0× larger
NEWT
$73.3M
$73.1M
EOLS
Growing faster (revenue YoY)
EOLS
EOLS
+9.4% gap
EOLS
6.7%
-2.7%
NEWT
Higher net margin
NEWT
NEWT
126.4% more per $
NEWT
111.8%
-14.6%
EOLS
Faster 2-yr revenue CAGR
NEWT
NEWT
Annualised
NEWT
12.2%
4.6%
EOLS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EOLS
EOLS
NEWT
NEWT
Revenue
$73.1M
$73.3M
Net Profit
$-10.7M
$19.5M
Gross Margin
66.9%
Operating Margin
23.8%
Net Margin
-14.6%
111.8%
Revenue YoY
6.7%
-2.7%
Net Profit YoY
6.6%
EPS (diluted)
$-0.16
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
NEWT
NEWT
Q1 26
$73.1M
Q4 25
$90.3M
$73.3M
Q3 25
$69.0M
$74.9M
Q2 25
$69.4M
$70.2M
Q1 25
$68.5M
$66.3M
Q4 24
$78.9M
$75.4M
Q3 24
$61.1M
$62.8M
Q2 24
$66.9M
$61.1M
Net Profit
EOLS
EOLS
NEWT
NEWT
Q1 26
$-10.7M
Q4 25
$130.0K
$19.5M
Q3 25
$-15.7M
$17.9M
Q2 25
$-17.1M
$13.7M
Q1 25
$-18.9M
$9.4M
Q4 24
$-6.8M
$18.3M
Q3 24
$-19.2M
$11.9M
Q2 24
$-11.3M
$10.9M
Gross Margin
EOLS
EOLS
NEWT
NEWT
Q1 26
66.9%
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Operating Margin
EOLS
EOLS
NEWT
NEWT
Q1 26
23.8%
Q4 25
4.7%
Q3 25
-16.7%
Q2 25
-14.7%
Q1 25
-22.1%
Q4 24
-2.9%
Q3 24
-25.3%
Q2 24
-11.5%
Net Margin
EOLS
EOLS
NEWT
NEWT
Q1 26
-14.6%
Q4 25
0.1%
111.8%
Q3 25
-22.8%
23.9%
Q2 25
-24.7%
19.5%
Q1 25
-27.6%
14.1%
Q4 24
-8.6%
24.3%
Q3 24
-31.4%
19.0%
Q2 24
-17.0%
17.9%
EPS (diluted)
EOLS
EOLS
NEWT
NEWT
Q1 26
$-0.16
Q4 25
$0.01
$0.64
Q3 25
$-0.24
$0.67
Q2 25
$-0.27
$0.52
Q1 25
$-0.30
$0.35
Q4 24
$-0.11
$0.70
Q3 24
$-0.30
$0.45
Q2 24
$-0.18
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
NEWT
NEWT
Cash + ST InvestmentsLiquidity on hand
$49.8M
Total DebtLower is stronger
$156.4M
$819.9M
Stockholders' EquityBook value
$397.6M
Total Assets
$220.6M
$2.7B
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
NEWT
NEWT
Q1 26
$49.8M
Q4 25
$53.8M
Q3 25
$43.5M
Q2 25
$61.7M
Q1 25
$67.9M
Q4 24
$87.0M
Q3 24
$85.0M
Q2 24
$93.7M
Total Debt
EOLS
EOLS
NEWT
NEWT
Q1 26
$156.4M
Q4 25
$146.1M
$819.9M
Q3 25
$748.5M
Q2 25
$657.3M
Q1 25
$121.8M
$774.0M
Q4 24
$121.5M
$708.0M
Q3 24
$121.2M
$655.8M
Q2 24
$120.9M
$652.0M
Stockholders' Equity
EOLS
EOLS
NEWT
NEWT
Q1 26
Q4 25
$-23.1M
$397.6M
Q3 25
$-28.8M
$386.7M
Q2 25
$-18.7M
$312.2M
Q1 25
$-6.6M
$302.3M
Q4 24
$5.5M
$296.3M
Q3 24
$5.9M
$281.8M
Q2 24
$19.3M
$274.0M
Total Assets
EOLS
EOLS
NEWT
NEWT
Q1 26
$220.6M
Q4 25
$225.9M
$2.7B
Q3 25
$219.0M
$2.4B
Q2 25
$228.8M
$2.1B
Q1 25
$213.4M
$2.1B
Q4 24
$232.6M
$2.1B
Q3 24
$229.6M
$1.7B
Q2 24
$233.8M
$1.6B
Debt / Equity
EOLS
EOLS
NEWT
NEWT
Q1 26
Q4 25
2.06×
Q3 25
1.94×
Q2 25
2.11×
Q1 25
2.56×
Q4 24
22.00×
2.39×
Q3 24
20.58×
2.33×
Q2 24
6.26×
2.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
NEWT
NEWT
Operating Cash FlowLast quarter
$-579.2M
Free Cash FlowOCF − Capex
$-579.3M
FCF MarginFCF / Revenue
-790.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-29.64×
TTM Free Cash FlowTrailing 4 quarters
$-1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
NEWT
NEWT
Q1 26
Q4 25
$12.8M
$-579.2M
Q3 25
$-14.7M
$-167.3M
Q2 25
$-24.8M
$-199.8M
Q1 25
$-15.6M
$-60.7M
Q4 24
$4.8M
$-153.0M
Q3 24
$-5.7M
$-25.7M
Q2 24
$-6.5M
$2.9M
Free Cash Flow
EOLS
EOLS
NEWT
NEWT
Q1 26
Q4 25
$11.3M
$-579.3M
Q3 25
$-15.6M
$-167.3M
Q2 25
$-25.5M
$-199.9M
Q1 25
$-16.0M
$-60.7M
Q4 24
$4.4M
$-153.5M
Q3 24
$-6.0M
$-25.9M
Q2 24
$-6.9M
$2.9M
FCF Margin
EOLS
EOLS
NEWT
NEWT
Q1 26
Q4 25
12.6%
-790.0%
Q3 25
-22.7%
-223.3%
Q2 25
-36.7%
-284.7%
Q1 25
-23.3%
-91.6%
Q4 24
5.5%
-203.6%
Q3 24
-9.9%
-41.2%
Q2 24
-10.4%
4.7%
Capex Intensity
EOLS
EOLS
NEWT
NEWT
Q1 26
Q4 25
1.6%
0.1%
Q3 25
1.4%
0.0%
Q2 25
1.0%
0.1%
Q1 25
0.5%
0.1%
Q4 24
0.6%
0.6%
Q3 24
0.5%
0.4%
Q2 24
0.7%
0.1%
Cash Conversion
EOLS
EOLS
NEWT
NEWT
Q1 26
Q4 25
98.67×
-29.64×
Q3 25
-9.35×
Q2 25
-14.58×
Q1 25
-6.48×
Q4 24
-8.35×
Q3 24
-2.15×
Q2 24
0.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

NEWT
NEWT

Segment breakdown not available.

Related Comparisons